Session Type
Meeting
Search Results for Mortality
Oral Presentations
Abstract Number: 9
SHM Converge 2023
Background: Mortality prediction models are increasingly being adopted in the clinical setting, both to retrospectively assess quality of care and to prospectively inform clinical practice. An open question is whether a particular hospital should employ a model trained using a diverse nationwide dataset or use a model developed primarily from local data. The Veterans Affairs […]
Oral Presentations
Abstract Number: 9
SHM Converge 2023
Background: Mortality prediction models are increasingly being adopted in the clinical setting, both to retrospectively assess quality of care and to prospectively inform clinical practice. An open question is whether a particular hospital should employ a model trained using a diverse nationwide dataset or use a model developed primarily from local data. The Veterans Affairs […]
Abstract Number: 86
SHM Converge 2023
Background: Deaths caused by drug overdose continue to be a public health crisis and contribute to overall mortality and the lowering of life expectancy in the United States. In 2021, the number of drug overdose deaths surged to nearly 107,000 nationally and more than 5,800 in New York State (NYS). Little is known about the […]
Abstract Number: 111
SHM Converge 2023
Background: Venous thromboembolism, in particular, pulmonary embolism (PE), is a significant contributor to morbidity and mortality associated with COVID-19. In comparison to influenza, COVID-19 leads to a more pronounced hypercoagulable state secondary to endotheliopathy and hyperinflammatory state which results in the formation of venous and arterial thrombosis. Based on prior literature, patients with COVID-19 have […]
Abstract Number: 120
SHM Converge 2023
Background: COVID-19 pandemic was vital in modifying healthcare delivery systems. This infection has led to variable composite outcomes in patients who have cardiovascular diseases [1,2]. In this study, we aimed to look into the impact of COVID-19 on incidence and outcomes of patients with Acute Myocardial Infarction using a nationally representative sample from the USA. […]
Abstract Number: 136
SHM Converge 2023
Background: The underlying burden of medical co-morbidity is often the main driver of ICU transfer of patients initially admitted to the medical wards (1). The role of non-patient related factors is unclear, as are the mortality and economic data associated with ICU transfer from the medical ward. The purpose of this analysis was to identify […]
Abstract Number: 141
SHM Converge 2023
Background: The COVID-19 pandemic was one of the biggest threats to human health, affecting health and health care delivery systems at both the individual and institutional level. There have been varied reports about how sociodemographic factors affect outcomes of patient with COVID-19 [1] [2] [3]. In this US claims based study, we analysed discharge data […]
Abstract Number: 144
SHM Converge 2023
Background: Coronavirus-19 (COVID-19), primarily a respiratory virus, can affect multiple organs, including the heart. Cardiac complications can affect 20-30% of COVID-19 patients and lead to worse morbidity and mortality. Cardiovascular complications can include myocarditis, acute myocardial infarction, heart failure, and arrhythmias Myocarditis is a well-known complication among COVID-19 infections, with limited large-scale studies evaluating outcomes […]
Abstract Number: 146
SHM Converge 2023
Background: In 2012, as part of Value based purchasing program, CMS instituted the Hospital Readmission Reduction program (HRRP). This aimed to decrease the number of unplanned readmission to the hospital for six conditions: Acute myocardial infarction(AMI),chronic obstructive pulmonary disease( COPD), Heart Failure (HF), Pneumonia ( PNA) , Coronary bypass graft(CABG), Elective total hip arthroplasty (THA) […]
Abstract Number: 148
SHM Converge 2023
Background: We observed improved survival among COVID-19 patients receiving remdesivir (RDV) during the early parts of the pandemic (Aug-Nov 2020) [1]. Clinical management of COVID-19 continues to develop over time as variants of concern (VOC) evolve. We extend the previous study to characterize outcomes for patients admitted on low-flow oxygen (LFO) and compare hospital all-cause […]